{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:34:14Z","timestamp":1778049254745,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.urolonc.2016.11.019","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T11:17:31Z","timestamp":1483615051000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicholas M.","family":"Donin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalit","family":"Strauss-Ayali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Agmon-Gerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadav","family":"Malchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan J.","family":"Pantuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie S.","family":"Belldegrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.11.019_bib1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","article-title":"Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.11.019_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.11.019_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.11.019_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bju.12341","article-title":"Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma","volume":"114","author":"Simhan","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.11.019_bib6","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/j.juro.2012.02.708","article-title":"Treatment of low stage urothelial carcinoma of the ureter: trends in utilization of endoscopic management","volume":"187","author":"Kohut","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib7","first-page":"e289","article-title":"The chemoablative effect of VesiGel\u00ae instillation in patients with NMIBC\u2014preliminary results","volume":"95","author":"Friedman","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib8","first-page":"3849","article-title":"Pharmacodynamics of mitomycin C in cultured human bladder tumors","volume":"51","author":"Schmittgen","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2016.11.019_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.2910510305","article-title":"Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times","volume":"51","author":"De Bruijn","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2016.11.019_bib10","article-title":"Sustained-release formulation of mitomycin C to the upper urinary tract using a thermosensitive polymer: a preclinical study","author":"Donin","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.11.019_bib11","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1097\/01.ju.0000138085.19352.b5","article-title":"Pig kidney: anatomical relationships between the intrarenal arteries and the kidney collecting system. Applied study for urological research and surgical training","volume":"172","author":"Pereira-Sampaio","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0022-5347(01)64902-4","article-title":"Microscopic study of the pig ureteral urothelium","volume":"157","author":"Desgrandchamps","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1354\/vp.36-2-167","article-title":"Mucinous vacuolar change of porcine urothelium induced by regional embolism or cryoablation","volume":"36","author":"Warner","year":"1999","journal-title":"Vet Pathol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.11.019_bib15","first-page":"5017","article-title":"Pharmacokinetics of mitomycin C in humans","volume":"43","author":"den Hartigh","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2016.11.019_bib16","first-page":"1633","article-title":"Phase I study of oral mitomycin C","volume":"60","author":"Crooke","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.urolonc.2016.11.019_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.55.9.641","article-title":"Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer","volume":"55","author":"Lopez-Beltran","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.urolonc.2016.11.019_bib18","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916304070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916304070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:09:36Z","timestamp":1761041376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916304070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1078143916304070"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.11.019","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}